Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Type 2 diabetes as an inflammatory disease.

Donath MY, Shoelson SE.

Nat Rev Immunol. 2011 Feb;11(2):98-107. doi: 10.1038/nri2925. Epub 2011 Jan 14. Review.

PMID:
21233852
2.

Inflammation and insulin resistance.

Shoelson SE, Lee J, Goldfine AB.

J Clin Invest. 2006 Jul;116(7):1793-801. Review. Erratum in: J Clin Invest. 2006 Aug;116(8):2308.

3.

Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes.

Sullivan TJ, Miao Z, Zhao BN, Ertl LS, Wang Y, Krasinski A, Walters MJ, Powers JP, Dairaghi DJ, Baumgart T, Seitz LC, Berahovich RD, Schall TJ, Jaen JC.

Metabolism. 2013 Nov;62(11):1623-32. doi: 10.1016/j.metabol.2013.06.008. Epub 2013 Aug 15.

PMID:
23953944
4.

Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes.

Goldfine AB, Silver R, Aldhahi W, Cai D, Tatro E, Lee J, Shoelson SE.

Clin Transl Sci. 2008 May;1(1):36-43. doi: 10.1111/j.1752-8062.2008.00026.x.

5.

The outliers become a stampede as immunometabolism reaches a tipping point.

Nikolajczyk BS, Jagannathan-Bogdan M, Denis GV.

Immunol Rev. 2012 Sep;249(1):253-75. doi: 10.1111/j.1600-065X.2012.01142.x. Review.

6.

IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat.

Ehses JA, Lacraz G, Giroix MH, Schmidlin F, Coulaud J, Kassis N, Irminger JC, Kergoat M, Portha B, Homo-Delarche F, Donath MY.

Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):13998-4003. doi: 10.1073/pnas.0810087106. Epub 2009 Jul 30.

7.

Elevated NF-κB activation is conserved in human myocytes cultured from obese type 2 diabetic patients and attenuated by AMP-activated protein kinase.

Green CJ, Pedersen M, Pedersen BK, Scheele C.

Diabetes. 2011 Nov;60(11):2810-9. doi: 10.2337/db11-0263. Epub 2011 Sep 12.

8.

Adipose tissue inflammation in the pathogenesis of type 2 diabetes.

Kohlgruber A, Lynch L.

Curr Diab Rep. 2015 Nov;15(11):92. doi: 10.1007/s11892-015-0670-x. Review.

PMID:
26374569
9.

Toll-like receptor 2/4 links to free fatty acid-induced inflammation and β-cell dysfunction.

Yin J, Peng Y, Wu J, Wang Y, Yao L.

J Leukoc Biol. 2014 Jan;95(1):47-52. doi: 10.1189/jlb.0313143. Epub 2013 Sep 9. Review.

10.

Is there a role for immune and anti-in-flammatory therapy in type 2 diabetes?

Sathyapalan T, Atkin SL.

Minerva Endocrinol. 2011 Jun;36(2):147-56. Review.

PMID:
21519323
11.

State of the union between metabolism and the immune system in type 2 diabetes.

Nikolajczyk BS, Jagannathan-Bogdan M, Shin H, Gyurko R.

Genes Immun. 2011 Jun;12(4):239-50. doi: 10.1038/gene.2011.14. Epub 2011 Mar 10. Review.

PMID:
21390053
13.

Interleukin-1 receptor antagonist (IL-1Ra) and IL-1Ra producing mesenchymal stem cells as modulators of diabetogenesis.

Volarevic V, Al-Qahtani A, Arsenijevic N, Pajovic S, Lukic ML.

Autoimmunity. 2010 Jun;43(4):255-63. doi: 10.3109/08916930903305641. Review.

PMID:
19845478
14.

Valsartan protects pancreatic islets and adipose tissue from the inflammatory and metabolic consequences of a high-fat diet in mice.

Cole BK, Keller SR, Wu R, Carter JD, Nadler JL, Nunemaker CS.

Hypertension. 2010 Mar;55(3):715-21. doi: 10.1161/HYPERTENSIONAHA.109.148049. Epub 2010 Jan 25.

15.

MECHANISMS IN ENDOCRINOLOGY: Metabolic and inflammatory pathways on the pathogenesis of type 2 diabetes.

Coope A, Torsoni AS, Velloso LA.

Eur J Endocrinol. 2016 May;174(5):R175-87. doi: 10.1530/EJE-15-1065. Epub 2015 Dec 8. Review.

16.

Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes.

Jagannathan-Bogdan M, McDonnell ME, Shin H, Rehman Q, Hasturk H, Apovian CM, Nikolajczyk BS.

J Immunol. 2011 Jan 15;186(2):1162-72. doi: 10.4049/jimmunol.1002615. Epub 2010 Dec 17.

18.

Macrophages, immunity, and metabolic disease.

McNelis JC, Olefsky JM.

Immunity. 2014 Jul 17;41(1):36-48. doi: 10.1016/j.immuni.2014.05.010. Review.

19.

The IL-1 Pathway in Type 2 Diabetes and Cardiovascular Complications.

Herder C, Dalmas E, Böni-Schnetzler M, Donath MY.

Trends Endocrinol Metab. 2015 Oct;26(10):551-63. doi: 10.1016/j.tem.2015.08.001. Review.

PMID:
26412156
20.

The role of inflammatory cytokines in diabetes and its complications.

King GL.

J Periodontol. 2008 Aug;79(8 Suppl):1527-34. doi: 10.1902/jop.2008.080246. Review.

PMID:
18673007

Supplemental Content

Support Center